study comparing Proscar (finasteride) with Hytrin (terazosin) for BPH is causing quite a stir

September 1996

The recently published study comparing Proscar (finasteride) with Hytrin (terazosin) for BPH is causing quite a stir.

News reports are saying Proscar is "virtually worthless"... prompting lots of calls from concerned patients.

This is the same study we alerted you to last year...it's just now been published in the New England Journal of Medicine.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote